Nimodipine and flunarizine have different effects on survival and morphology of PC12 cells during nerve growth factor deprivation

European Journal of Pharmacology

Volumn 384, Issue 1, 1999, Pages 61-70

  Dispersyn, Gwenda ^a   Nuydens, Rony ^b,c   Borgers, Marcel ^a,b,c   Geerts, Hugo ^c  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Ca2+; Cell death; Neurite; NGF; PC12 cell

Indexed keywords

1,2 BIS(2 AMINOPHENOXY)ETHANE N,N,N',N' TETRAACETIC ACID ACETOXYMETHYL ESTER; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHELATING AGENT; CALCIUM ION; EGTAZIC ACID; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FLUNARIZINE; NERVE GROWTH FACTOR; NIMODIPINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL PROTECTION; CELL STRAIN; CELL STRUCTURE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; IMAGE ANALYSIS; MICROSCOPY; NEURITE; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELL SURVIVAL; CHELATING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EGTAZIC ACID; FLUNARIZINE; NERVE GROWTH FACTOR; NEURITES; NIMODIPINE; PC12 CELLS; RATS;

EID: 0032804141     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00665-2     Document Type: Article

References (50)

1. Batistatou A., Greene L.A. Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity. J. Cell Biol. 115:1991;461-471.
2. Batistatou A., Volonte C., Greene L.A. Nerve growth factor employs multiple pathways to induce primary response genes in PC12 cells. Mol. Biol. Cell. 3:1992;363-371.
3. Burstein D.E., Greene L.A. Evidence for RNA synthesis-dependent and independent pathways in stimulation of neurite outgrowth by nerve growth factor. Proc. Natl. Acad. Sci. U.S.A. 75:1978;6059-6063.
4. Cheng B., Mattson M.P. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron. 7:1991;1031-1041.
5. Cheng B., Mattson M.P. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J. Neurosci. 12:1992;1558-1566.
6. Choi D.W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends. Neurosci. 11:1988;465-469.
7. 2+ buffering, a cell property that in some neurons markedly decreases during aging, has a protective effect against NMDA/nitric oxide-induced excitotoxicity. Life Sci. 59:1996;389-397.
8. Collins F., Schmidt M.F., Guthrie P.B., Kater S.B. Sustained increase in intracellular calcium promotes neuronal survival. J. Neurosci. 11:1991;2582-2587.
9. 2+] homeostasis in PC12 cells after nerve growth factor deprivation. Brain Res. 779:1998;350-353.
10. Dowd D.R. Calcium regulation of apoptosis. Adv. Second Messenger Phosphoprotein Res. 30:1995;255-280.
11. Eichler M.E., Dubinsky J.M., Rich K.M. Relationship of intracellular calcium to dependence on nerve growth factor in dorsal root ganglion neurons in cell culture. J. Neurochem. 58:1992;263-269.
12. Eichler M.E., Dubinsky J.M., Tong J., Rich K.M. The ability of diphenylpiperazines to prevent neuronal death in dorsal root ganglion neurons in vitro after nerve growth factor deprivation and in vivo after axotomy. J. Neurochem. 62:1994;2148-2157.
13. Franklin J.L., Johnson E.M. Jr. Suppression of programmed neuronal death by sustained elevation of cytoplasmic calcium. Trends. Neurosci. 15:1992;501-508.
14. Greene L.A. Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium. J. Cell Biol. 78:1978;747-755.
15. Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U.S.A. 73:1976;2424-2428.
16. 2+ determine nerve growth factor dependence of sympathetic ganglion cells. Proc. Natl. Acad. Sci. U.S.A. 86:1989;6421-6425.
17. Kroemer G., Petit P., Zamzami N., Vayssiere J.L., Mignotte B. The biochemistry of programmed cell death. FASEB J. 9:1995;1277-1287.
18. Levi A., Alema S. The mechanism of action of nerve growth factor. Annu. Rev. Pharmacol. Toxicol. 31:1991;205-228.
19. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 237:1987;1154-1162.
20. Lindenboim L., Haviv R., Stein R. Inhibition of drug-induced apoptosis by survival factors in PC12 cells. J. Neurochem. 64:1995;1054-1063.
21. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330:1994;613-622.
22. Martin D.P., Schmidt R.E., DiStefano P.S., Lowry O.H., Carter J.G., Johnson E.M. Jr. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J. Cell Biol. 106:1988;829-844.
23. Martin S.J., Green D.R., Cotter T.G. Dicing with death: dissecting the components of the apoptosis machinery. Trends. Biochem. Sci. 19:1994;26-30.
24. McConkey D.J., Orrenius S. Calcium and cyclosporin A in the regulation of apoptosis. Curr. Top. Microbiol. Immunol. 200:1995;95-105.
25. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends. Pharmacol. Sci. 11:1990;379-387.
26. Merrick S.E., Trojanowski J.Q., Lee V.M. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J. Neurosci. 17:1997;5726-5737.
27. Mesner P.W., Winters T.R., Green S.H. Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons. J. Cell Biol. 119:1992;1669-1680.
28. Mignotte B., Vayssiere J.L. Mitochondria and apoptosis. Eur. J. Biochem. 252:1998;1-15.
29. 2+ homeostasis. Prog. Neurobiol. 37:1991;255-285.
30. + and cyclic AMP in the presence or absence of NGF. Eur. J. Neurosci. 5:1993;1261-1272.
31. Nicotera P., Bellomo G., Orrenius S. Calcium-mediated mechanisms in chemically induced cell death. Annu. Rev. Pharmacol. Toxicol. 32:1992;449-470.
32. Nuydens R., Dispersyn G., de Jong M., Van Den Kieboom G., Borgers M., Geerts H. Aberrant tau phosphorylation and neurite retraction during NGF deprivation in PC12 cells. Biochem. Biophys. Res. Commun. 240:1997;687-691.
33. Nuydens R., de Jong M., Van Den Kieboom G., Heers C., Dispersyn G., Cornelissen F., Nuyens R., Borgers M., Geerts H. Okadaic acid-induced apoptosis in neuronal cells: evidence for an abortive mitotic attempt. J. Neurochem. 70:1998;1124-1133.
34. Oppenheim R.W., Prevette D., Tytell M., Homma S. Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis: evidence for the role of cell death genes. Dev. Biol. 138:1990;104-113.
35. Reber B.F., Bouron A. Calyculin-A-induced fast neurite retraction in nerve growth factor-differentiated rat pheochromocytoma (PC12) cells. Neurosci. Lett. 183:1995;198-201.
36. Rich K.M., Hollowell J.P. Flunarizine protects neurons from death after axotomy or NGF deprivation. Science. 248:1990;1419-1421.
37. Rukenstein A., Rydel R.E., Greene L.A. Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms. J. Neurosci. 11:1991;2552-2563.
38. Scott S.A., Davies A.M. Inhibition of protein synthesis prevents cell death in sensory and parasympathetic neurons deprived of neurotrophic factor in vitro. J. Neurobiol. 21:1990;630-638.
39. Scott B.S., Fisher K.C. Potassium concentration and number of neurons in cultures of dissociated ganglia. Exp. Neurol. 27:1970;16-22.
40. Teng K.K., Greene L.A. Depolarization maintains neurites and priming of PC12 cells after nerve growth factor withdrawal. J. Neurosci. 13:1993;3124-3135.
41. Thomas P.G., Seelig J. Binding of the calcium antagonist flunarizine to phosphatidylcholine bilayers: charge effects and thermodynamics. Biochem. J. 291:1993;397-402.
42. Trump B.F., Berezesky I.K. Calcium-mediated cell injury and cell death. FASEB J. 9:1995;219-228.
43. 2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo. Neuron. 11:1993;221-235.
44. 2+ chelators. J. Cereb. Blood Flow Metab. 14:1994;911-923.
45. 2+ transport. Eur. J. Pharmacol. 289:1995;73-80.
46. Vanhoutte P.M., Paoletti R. The WHO classification of calcium antagonists. Trends Pharmacol. Sci. 8:1987;4-5.
47. Villarroya M., Gandia L., Lara B., Albillos A., Lopez M.G., Garcia A.G. Dotarizine versus flunarizine as calcium antagonists in chromaffin cells. Br. J. Pharmacol. 114:1995;369-376.
48. Wei H., Wei W., Bredesen D.E., Perry D.C. Bcl-2 protects against apoptosis in neuronal cell line caused by thapsigargin-induced depletion of intracellular calcium stores. J. Neurochem. 70:1998;2305-2314.
49. Yu S.P., Yeh C.H., Sensi S.L., Gwag B.J., Canzoniero L.M., Farhangrazi Z.S., Ying H.S., Tian M., Dugan L.L., Choi D.W. Mediation of neuronal apoptosis by enhancement of outward potassium current. Science. 278:1997;114-117.
50. 2+ levels increased by high-potassium or glutamate in cultured rat cerebellar granule cells. Jpn. J. Pharmacol. 62:1993;411-414.